Skip to main content
Top
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Research

Voice analysis after cancer treatment with organ preservation

Authors: Renata JDS Campos, Cristina TV Maciel, Marcelle G Cesca, Isabel CG Leite

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Background

This cross-sectional study objects to measure, subjectively and objectively, the voice and life quality of patients with oral cavity, pharyngeal and laryngeal cancer, after organ-preservation treatment.

Methods

25 cases diagnosed and treated at a high complexity oncology center in southeastern Brazil. All had oral cavity, pharyngeal or laryngeal cancer, with a therapeutic proposal of radiotherapy alone or simultaneous radiochemotherapy. Acoustic voice analysis and the Voice Handicap Index protocol were used to measure voice quality. The data were analyzed through the χ2, Student's t and Kruskal Wallis tests. Significance level was 5%.

Results

After treatment, 40% complained of hoarseness, 56% complained of throat clearing, and no patient reported aphonia. On the voice quality auditory scale, 36% had moderate dysphonia. Acoustic voice analysis ranged from 184 to 221 Hz in females, and from 92 to 241 Hz in males. As for quality of life, most patients had mild physical, functional and emotional handicaps.

Conclusions

Chemio-radiation organ preservation protocols in the patients studied may leave the organ but with reduced function which brings communication sequelae. In such cases, voice assessment and quality of life protocols, as well as speech therapy rehabilitation, are important tools to preserve function, measure and treat alterations, and reintegrate patients into the community.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eksteen EC, Rieger J, Nesbitt M, Seikalv H: Comparison of voice characteristics following three different methods of treatment for laryngeal cancer. J Otolaryngol. 2003, 32 (Suppl 4): 250-3.CrossRefPubMed Eksteen EC, Rieger J, Nesbitt M, Seikalv H: Comparison of voice characteristics following three different methods of treatment for laryngeal cancer. J Otolaryngol. 2003, 32 (Suppl 4): 250-3.CrossRefPubMed
2.
go back to reference Costa Bandeira AK, Azevedo EH, Vartanian JG, Nishimoto IN, Kowalski LP, Carrara-de Angelis E: Quality of life related to swallowing after tongue cancer treatment. Dysphagia. 2008, 23 (Suppl 2): 183-192.CrossRefPubMed Costa Bandeira AK, Azevedo EH, Vartanian JG, Nishimoto IN, Kowalski LP, Carrara-de Angelis E: Quality of life related to swallowing after tongue cancer treatment. Dysphagia. 2008, 23 (Suppl 2): 183-192.CrossRefPubMed
3.
go back to reference Jacobson BH, Johson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS: The voice Handicap Index (VHI): Development and validation. Am J Speech Lang Pathol. 1997, 6: 66-70.CrossRef Jacobson BH, Johson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS: The voice Handicap Index (VHI): Development and validation. Am J Speech Lang Pathol. 1997, 6: 66-70.CrossRef
5.
go back to reference Rehder MI, Behlau M: Perceptual, auditory and acoustic vocal analysis of speech and singing in choir conductors. Pro Fono. 2008, 20 (Suppl3): 195-200.PubMed Rehder MI, Behlau M: Perceptual, auditory and acoustic vocal analysis of speech and singing in choir conductors. Pro Fono. 2008, 20 (Suppl3): 195-200.PubMed
6.
go back to reference Sampaio M, Oliveira G, Behlau M: Investigação de efeitos imediatos de dois exercícios de trato vocal semi-ocluído. Pró-Fono Revista de Atualização Científica. 2008, 20 (Suppl 4): 261-6.CrossRefPubMed Sampaio M, Oliveira G, Behlau M: Investigação de efeitos imediatos de dois exercícios de trato vocal semi-ocluído. Pró-Fono Revista de Atualização Científica. 2008, 20 (Suppl 4): 261-6.CrossRefPubMed
7.
go back to reference Moerman M, Martens JP, Dejonckere P: Application of the Voice Handicap Index in 45 patients with substitution voicing after total laryngectomy. Eur Arch Otorhinolaryngol. 2004, 261 (Suppl 8): 423-8.PubMed Moerman M, Martens JP, Dejonckere P: Application of the Voice Handicap Index in 45 patients with substitution voicing after total laryngectomy. Eur Arch Otorhinolaryngol. 2004, 261 (Suppl 8): 423-8.PubMed
8.
go back to reference SPSS INCORPORATION: SPSS for Windows. Statistical Package for Social Sciences. Release 15.0. 2006, Chicago: SPSS Inc SPSS INCORPORATION: SPSS for Windows. Statistical Package for Social Sciences. Release 15.0. 2006, Chicago: SPSS Inc
10.
go back to reference Hirsch SM, Caldarelli DD, Hutchinson JC, et al: Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope. 1991, 101 (6 Pt 1): 583-6.PubMed Hirsch SM, Caldarelli DD, Hutchinson JC, et al: Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope. 1991, 101 (6 Pt 1): 583-6.PubMed
11.
go back to reference Leeper HA, Parsa V, Jamieson DG, Heeneman H: Acoustical Aspects of Vocal Function Following Radiotherapy for Early T1a Laryngeal Cancer. Journal of Voice. 2002, 16 (Suppl 2): 289-302.CrossRefPubMed Leeper HA, Parsa V, Jamieson DG, Heeneman H: Acoustical Aspects of Vocal Function Following Radiotherapy for Early T1a Laryngeal Cancer. Journal of Voice. 2002, 16 (Suppl 2): 289-302.CrossRefPubMed
12.
go back to reference Behrman A, Abramson AL, Myssiorek DAA: Comparison of radiation of radiation-induced and prebylaryngeal dysphonia. Otolaryngology Head neck surgery. 2001, 125: 193-200. 10.1067/mhn.2001.117411.CrossRefPubMed Behrman A, Abramson AL, Myssiorek DAA: Comparison of radiation of radiation-induced and prebylaryngeal dysphonia. Otolaryngology Head neck surgery. 2001, 125: 193-200. 10.1067/mhn.2001.117411.CrossRefPubMed
13.
go back to reference Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP: Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg. 2003, 129: 733-738.CrossRefPubMed Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP: Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg. 2003, 129: 733-738.CrossRefPubMed
14.
go back to reference Caminero CMJ, Señaris GB, López LA, Núñez BF, Alonso PR, Suárez NC: Voice quality assessment after laryngeal cancer radiotherapeutic treatment at initial stages. Clin Transl Oncol. 2006, 8 (Suppl 4): 284-9. Caminero CMJ, Señaris GB, López LA, Núñez BF, Alonso PR, Suárez NC: Voice quality assessment after laryngeal cancer radiotherapeutic treatment at initial stages. Clin Transl Oncol. 2006, 8 (Suppl 4): 284-9.
15.
go back to reference Van Goch CD, et al: The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer. 2006, 106 (Suppl 1): 95-105.CrossRef Van Goch CD, et al: The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer. 2006, 106 (Suppl 1): 95-105.CrossRef
Metadata
Title
Voice analysis after cancer treatment with organ preservation
Authors
Renata JDS Campos
Cristina TV Maciel
Marcelle G Cesca
Isabel CG Leite
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-19

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine